These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


203 related items for PubMed ID: 16546970

  • 1. Radiosensitization by the poly(ADP-ribose) polymerase inhibitor 4-amino-1,8-naphthalimide is specific of the S phase of the cell cycle and involves arrest of DNA synthesis.
    Noël G, Godon C, Fernet M, Giocanti N, Mégnin-Chanet F, Favaudon V.
    Mol Cancer Ther; 2006 Mar; 5(3):564-74. PubMed ID: 16546970
    [Abstract] [Full Text] [Related]

  • 2. 4-Amino-1,8-naphthalimide: a novel inhibitor of poly(ADP-ribose) polymerase and radiation sensitizer.
    Schlicker A, Peschke P, Bürkle A, Hahn EW, Kim JH.
    Int J Radiat Biol; 1999 Jan; 75(1):91-100. PubMed ID: 9972795
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair.
    Bryant HE, Helleday T.
    Nucleic Acids Res; 2006 Jan; 34(6):1685-91. PubMed ID: 16556909
    [Abstract] [Full Text] [Related]

  • 4. PARP inhibition versus PARP-1 silencing: different outcomes in terms of single-strand break repair and radiation susceptibility.
    Godon C, Cordelières FP, Biard D, Giocanti N, Mégnin-Chanet F, Hall J, Favaudon V.
    Nucleic Acids Res; 2008 Aug; 36(13):4454-64. PubMed ID: 18603595
    [Abstract] [Full Text] [Related]

  • 5. Sensitization to radiation and alkylating agents by inhibitors of poly(ADP-ribose) polymerase is enhanced in cells deficient in DNA double-strand break repair.
    Löser DA, Shibata A, Shibata AK, Woodbine LJ, Jeggo PA, Chalmers AJ.
    Mol Cancer Ther; 2010 Jun; 9(6):1775-87. PubMed ID: 20530711
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. PARP inhibition sensitizes p53-deficient breast cancer cells to doxorubicin-induced apoptosis.
    Muñoz-Gámez JA, Martín-Oliva D, Aguilar-Quesada R, Cañuelo A, Nuñez MI, Valenzuela MT, Ruiz de Almodóvar JM, De Murcia G, Oliver FJ.
    Biochem J; 2005 Feb 15; 386(Pt 1):119-25. PubMed ID: 15456408
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Requirement for NBS1 in the S phase checkpoint response to DNA methylation combined with PARP inhibition.
    Horton JK, Stefanick DF, Zeng JY, Carrozza MJ, Wilson SH.
    DNA Repair (Amst); 2011 Feb 07; 10(2):225-34. PubMed ID: 21130714
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Induction of apoptosis by the inhibitors of poly(ADP-ribose)polymerase in HeLa cells.
    Ghosh U, Bhattacharyya NP.
    Mol Cell Biochem; 2009 Jan 07; 320(1-2):15-23. PubMed ID: 18695944
    [Abstract] [Full Text] [Related]

  • 12. Poly(ADP-ribose) polymerase (PARP-1) is not involved in DNA double-strand break recovery.
    Noël G, Giocanti N, Fernet M, Mégnin-Chanet F, Favaudon V.
    BMC Cell Biol; 2003 Jul 16; 4():7. PubMed ID: 12866953
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Poly(ADP-ribose) polymerase inhibition reduces tumor necrosis factor-induced inflammatory response in rheumatoid synovial fibroblasts.
    García S, Bodaño A, Pablos JL, Gómez-Reino JJ, Conde C.
    Ann Rheum Dis; 2008 May 16; 67(5):631-7. PubMed ID: 17890271
    [Abstract] [Full Text] [Related]

  • 19. ATR signaling mediates an S-phase checkpoint after inhibition of poly(ADP-ribose) polymerase activity.
    Horton JK, Stefanick DF, Kedar PS, Wilson SH.
    DNA Repair (Amst); 2007 Jun 01; 6(6):742-50. PubMed ID: 17292679
    [Abstract] [Full Text] [Related]

  • 20. Predicting enhanced cell killing through PARP inhibition.
    Horton JK, Wilson SH.
    Mol Cancer Res; 2013 Jan 01; 11(1):13-8. PubMed ID: 23193155
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.